|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Gross margin | |||||
| Distribution expenses | |||||
| Selling, general and administrative expenses | |||||
| Intangible asset impairments | |||||
| Restructuring expenses | |||||
| Wallace facility remediation expense | |||||
| (Loss) income from operations | |||||
| Interest expense | |||||
| Mark to market loss on interest rate derivatives | |||||
| Loss on equity securities | |||||
| (Loss) income before income taxes and equity in losses | |||||
| Income tax benefit (provision) | |||||
| Equity in losses, net of taxes | |||||
| NET LOSS | |||||
| BASIC LOSS PER COMMON SHARE (usd per share) | |||||
| DILUTED LOSS PER COMMON SHARE (usd per share) |
Loading...
